SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories - Quaterly Results

11 Nov 2024 Evaluate
With no major difference for the quarter endedSeptember 2024 , the total revenue stood at Rs. 3837.00  millions.The Profit  for the quarter ended September 2024 of  Rs. 319.28  millions  grew by 60.25% from Rs. 199.24 millions.OP of the company witnessed a marginal growth to 476.96 millions from 325.99 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 3837.00 3812.58 0.64 7693.43 7503.61 2.53 15375.94 13388.83 14.84
Other Income 46.31 28.38 63.18 77.03 49.22 56.50 125.66 57.59 118.20
PBIDT 476.96 325.99 46.31 993.78 594.86 67.06 1743.84 830.29 110.03
Interest 10.50 4.55 130.77 20.94 7.38 183.74 35.09 19.81 77.13
PBDT 466.46 321.44 45.12 972.84 587.48 65.60 1708.75 810.48 110.83
Depreciation 37.90 48.10 -21.21 73.80 97.03 -23.94 219.00 180.06 21.63
PBT 428.56 273.34 56.79 899.04 490.45 83.31 1489.75 630.42 136.31
TAX 109.28 74.10 47.48 229.26 132.72 72.74 380.40 167.99 126.44
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -4.36 2.03 -314.78
PAT 319.28 199.24 60.25 669.78 357.73 87.23 1109.35 462.43 139.90
Equity 1095.84 1022.27 7.20 1095.84 1022.27 7.20 1022.27 1022.27 0.00
PBIDTM(%) 12.43 8.55 45.38 12.92 7.93 62.94 11.34 6.20 82.88

Morepen Laboratories Share Price

41.92 0.79 (1.92%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×